Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes

• Yen T. Duong,

  Affiliation International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Reshma Kassanjee,

  Affiliations The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa, School of Computational and Applied Mathematics, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Alex Welte,

  Affiliation The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa

  ⨯
• Meade Morgan,

  Affiliation Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Anindya De,

  Affiliation Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Trudy Dobbs,

  Affiliation International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Erin Rottinghaus,

  Affiliation International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• John Nkengasong,

  Affiliation International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Marcel E. Curlin,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Chonticha Kittinunvorakoon,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Boonyos Raengsakulrach,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Michael Martin,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Kachit Choopanya,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Suphak Vanichseni,

  Affiliation Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand

  ⨯
• Yan Jiang,

  Affiliation National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Maofeng Qiu,

  Affiliation National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Haiying Yu,

  Affiliation National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Yan Hao,

  Affiliation National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Neha Shah,

  Affiliation California Department of Public Health, Richmond, California, United States of America

  ⨯
• Linh-Vi Le,

  Affiliation Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Hanoi, Vietnam

  ⨯
• Andrea A. Kim,

  Affiliation CDC-Kenya, Nairobi, Kenya

  ⨯
• Tuan Anh Nguyen,

  Affiliation National Institute of Hygiene and Epidemiology, Hanoi, Vietnam

  ⨯
• William Ampofo,

  Affiliation Noguchi Memorial Institute for Medical Research, Accra, Ghana

  ⨯
•  [ ... ],
• Bharat S. Parekh

  * E-mail: bparekh@cdc.gov

  Affiliation International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• [ view all ]
• [ view less ]